IBI110,Sintilimab
eli lilly,Innovent Biologics
['ibi110', '$ivbxf', 'innovent']
$ivbxf - innovent presents phase 1b clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2023 asco annual meeting 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.